~~<i id='380FBA9C57'><strike id='380FBA9C57'><tt id='380FBA9C57'><pre id='380FBA9C57'></pre></tt></strike></i>~~

Home» focus» comprehensive

comprehensive

author：hotspot 2025-09-30 03:22:54 Page View：72

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Presidential fundraising highlights so far: Trump brings in more than DeSantis
Next article： 23andMe had bad news about my health. I wish a person had delivered it

explore

Sports medicine is finally prioritizing gender equality

MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

5:03PeopleraiseuptheirarmsduringthededicationofaprayerwalloutsideofthehistoricVernonAfricanMethodist

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

What causes rare myocarditis in young men after Covid vaccines?

AdobeAnewstudyshedslightonwhatmaybecausingveryrarecasesofheartinflammationinyoungmenafterreceivingan